ArticleFrontiers in pharmacology2025
A comprehensive bibliometric exploration of hydrogel applications in spinal cord injury.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research Evolution and Frontiers in Glial Scar and Spinal Cord Injury Research: A Bibliometric Perspective.Brain and behavior · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Spinal cord injury (SCI) represents a severe traumatic disorder of the central nervous system, leading to potential loss of motor and sensory functions. Its intricate pathological mechanism renders its treatment a formidable challenge. Recently, hydrogels have emerged as promising materials for spinal cord repair due to their exceptional biocompatibility and biodegradability, garnering significant attention. Consequently, extensive research on hydrogel applications in spinal cord injuries aims to provide an in-depth understanding of this field's current state and delineate future research trajectories. Methods: A thorough search was conducted using the Web of Science Core Collection (WoSCC). Bibliometric tools such as CiteSpace, VOSviewer, Scimago Graphica, R and Bibliometrix software were employed to construct a knowledge map regarding the application of hydrogel in SCI. Results: A bibliometric analysis of 1,015 publications between 2000 and 2025 elucidates the current research landscape, developmental trends, academic impact, and emerging knowledge dissemination patterns in hydrogel applications for SCI. The international collaboration in hydrogels-based SCI research exhibits a China-U.S.-centered network structure: as the top two publishing countries (464 vs. 278 publications), they maintain the closest bilateral collaboration, collectively forming a prominent transnational research network. The journal Biomaterials boasts the highest number of publications with 58 articles. Among prolific authors, Shoichet, Molly S., has authored the most papers, totaling 38 articles. There is a notable collaboration among various countries and institutions, with current research predominantly focusing on inflammation, apoptosis, nanoparticles, and injectable hydrogels. These efforts aim to achieve functionalized hydrogel regulation of microenvironmental changes, emerging as a focal point in contemporary research. This research highlights the latest trend of hydrogels in the treatment of SCI, thus pointing out the direction for new treatment strategies. Discussion: The current research focus, which include the integration of functionalized hydrogels with biological factors, are setting the stage for subsequent investigative endeavors and the eventual clinical application of hydrogel in the treatment of SCI. This comprehensive analysis not only delineates the current state and emerging frontiers of hydrogel-based treatments for SCI but also provides a roadmap for future innovation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.